Beijing Tong Ren Tang Chinese Medicine Company Limited Stock
Equities
3613
HK0000145638
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.71 HKD | +0.62% | +1.15% | -20.02% |
Sales 2024 * | 1.74B 222M | Sales 2025 * | 1.99B 255M | Capitalization | 8.08B 1.03B |
---|---|---|---|---|---|
Net income 2024 * | 652M 83.5M | Net income 2025 * | 758M 97.07M | EV / Sales 2024 * | 3.02 x |
Net cash position 2024 * | 2.83B 363M | Net cash position 2025 * | 2.63B 337M | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
9.62
x | Employees | 798 |
Yield 2024 * |
4.15% | Yield 2025 * |
4.82% | Free-Float | 28.23% |
1 day | +0.93% | ||
1 week | +1.46% | ||
Current month | +1.78% | ||
1 month | +0.62% | ||
3 months | +3.84% | ||
6 months | -22.20% | ||
Current year | -19.77% |
Managers | Title | Age | Since |
---|---|---|---|
Fung Yi Tsang
DFI | Director of Finance/CFO | 48 | 12-09-30 |
Xia Li
CTO | Chief Tech/Sci/R&D Officer | 54 | 07-12-31 |
Fei Chen
BRD | Director/Board Member | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ngai Chi Chan
BRD | Director/Board Member | 52 | 13-04-14 |
Hai Ou Gu
CHM | Chairman | 58 | Dec. 12 |
Yok Sing Tsang
BRD | Director/Board Member | 76 | 17-09-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 9.71 | +0.62% | 267 000 |
24-06-04 | 9.65 | +2.01% | 694,000 |
24-06-03 | 9.46 | -1.15% | 916,000 |
24-05-31 | 9.57 | +0.63% | 1,685,000 |
24-05-30 | 9.51 | -0.94% | 791,000 |
Delayed Quote Hong Kong S.E., June 04, 2024 at 09:55 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.77% | 1.01B | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- 3613 Stock